1 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 340 of 1020 | 1380 prescriptions Less than 1% of all prescriptions | 1170 | 440 patients 19% of all patients | < 11 | |
2 MONTELUKAST SODIUM | 410 of 940 | 890 prescriptions Less than 1% of all prescriptions | 570 | 330 patients 14% of all patients | < 11 | |
3 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 330 of 930 | 1260 prescriptions Less than 1% of all prescriptions | | 330 patients 14% of all patients | < 11 | |
4 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 270 of 910 | 900 prescriptions Less than 1% of all prescriptions | 770 | 270 patients 11% of all patients | < 11 | |
5 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 220 of 740 | 510 prescriptions Less than 1% of all prescriptions | | 180 patients 8% of all patients | < 11 | |
6 VENTOLIN HFA (ALBUTEROL SULFATE) | 600 of 1070 | 710 prescriptions Less than 1% of all prescriptions | | 350 patients 15% of all patients | < 11 | |
7 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 620 of 990 | 390 prescriptions Less than 1% of all prescriptions | | 120 patients 5% of all patients | < 11 | |
8 SPIRIVA (TIOTROPIUM BROMIDE) | 490 of 820 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
9 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 420 of 720 | 230 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
10 CLONAZEPAM | 140 of 210 | 230 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
11 PREDNISONE | 680 of 1100 | 320 prescriptions Less than 1% of all prescriptions | | 250 patients 11% of all patients | < 11 | |
12 AZITHROMYCIN | 490 of 800 | 230 prescriptions Less than 1% of all prescriptions | | 130 patients 5% of all patients | < 11 | A |
13 DALIRESP (ROFLUMILAST) | 360 of 510 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
14 PROAIR HFA (ALBUTEROL SULFATE) | 510 of 790 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
15 DOXYCYCLINE HYCLATE | 200 of 350 | 150 prescriptions Less than 1% of all prescriptions | 150 | 140 patients 6% of all patients | 140 patients 6% of all patients | A |